BAFF and APRIL immunotherapy following Bacille Calmette-Guérin vaccination enhances protection against pulmonary tuberculosis in mice
IntroductionBacille Calmette-Guérin (BCG), the only tuberculosis vaccine currently in clinical use, provides inadequate long-term protection. Administered at birth, BCG induces broad immune responses against a large number of antigens shared with Mycobacterium tuberculosis (Mtb), but protection wane...
Saved in:
Main Authors: | Min Xie, Chen-Yu Tsai, Joshua Woo, Frank Nuritdinov, Melissa Cristaldo, Narineh M. Odjourian, Rosleine Antilus-Sainte, Maureen Dougher, Martin Gengenbacher |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1551183/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Primary central nervous system lymphoma: Comprehension of cell-of-origin subtypes
by: Shruti Rao, et al.
Published: (2023-07-01) -
Editorial: T and B cell immune dynamics in allergic response
by: Mrinmoy Das, et al.
Published: (2025-02-01) -
Targets of influenza human T-cell response are mostly conserved in H5N1
by: John Sidney, et al.
Published: (2025-02-01) -
Editorial: Tuberculosis and humoral immunity
by: Taru S. Dutt, et al.
Published: (2025-02-01) -
B Cell Activation, Differentiation, and Their Potential Molecular Mechanisms in Osteoarthritic Synovial Tissue
by: Lu P, et al.
Published: (2025-02-01)